Annual Meeting of Shareholders to be Held May 31, 2007
SAN DIEGO, Mar 07, 2007 (BUSINESS WIRE) -- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) will hold a conference call to discuss 2006 fourth quarter financial results and provide an update on recent events on Thursday, March 15, 2007, beginning at 1:30 p.m. Pacific time (4:30 p.m. Eastern time). A press release announcing the quarterly results will be issued March 15, 2007 following the close of market.
To participate in the call via telephone, please dial (800) 323-0845 from the U.S. or (706) 634-8407 from outside the U.S. A replay of the call will be available until March 17, 2007 at 2:30 p.m. Pacific time (5:30 p.m. Eastern time) by dialing (800) 642-1687 from the U.S. or (706) 645-9291 from outside the U.S., and entering passcode 2147471. Individual investors can access the Webcast through CCBN's Individual Investor Center at www.earnings.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors can access the Webcast via CCBN's password-protected event management site, StreetEvents (www.streetevents.com).
Separately, the Company announced that its 2006 Annual Meeting of Shareholders will be held May 31, 2007, beginning at 8:30 a.m. Pacific time at Ligand Pharmaceuticals Inc., 10275 Science Center Drive, San Diego, California 92121.
About Ligand
Ligand discovers and develops new drugs that address critical unmet medical needs of patients in the areas of thrombocytopenia, cancer, hepatitis C, hormone-related diseases, osteoporosis and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to Intracellular Receptors.
SOURCE: Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Incorporated
John L. Higgins, President and CEO
or
Erika Luib-De la Cruz, Investor Relations
(858) 550-7896
or
Lippert/Heilshorn & Associates
Don Markley
dmarkley@lhai.com
(310) 691-7100
